Mechanisms underlying off-target effects of the cholesteryl ester transfer protein inhibitor torcetrapib involve L-type calcium channels-Reference-Cited by-同舟云学术

Mechanisms underlying off-target effects of the cholesteryl ester transfer protein inhibitor torcetrapib involve L-type calcium channels

Published:2010-08 Issue:8 Volume:28 Page:1676-1686
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Clerc Roger G,Stauffer Andrea,Weibel Franziska,Hainaut Emmanuelle,Perez Anne,Hoflack Jean-Christophe,Bénardeau Agnès,Pflieger Philippe,Garriz Jose MR,Funder John W,Capponi Alessandro M,Niesor Eric J

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference26 articles.

1. Effects of torcetrapib in patients at high risk for coronary events;Barter;N Engl J Med,2007

2. Cholesteryl ester transfer protein inhibitor torcetrapib and off-target toxicity. A pooled analysis of the Rating Atherosclerotic Disease change by Imaging with A New CETP Inhibitor (RADIANCE) Trials;Vergeer;Circulation,2008

3. ILLUSTRATE Investigators. Effect of torcetrapib on the progression of coronary atherosclerosis. N Engl J Med 2007; 356:1304-1316.;Nissen;Erratum in N Engl J Med,2007

4. A role for the NGFI-B family in adrenal zonation and adrenocortical disease;Bassett;Endocr Res,2004

5. T channels and steroid biosynthesis: in search of a link with mitochondria;Rossier;Cell Calcium,2006

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Assays in Endocrine Safety Pharmacology;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2024

2. Epidemiology, Control, and Cardiovascular Outcomes of Dyslipidemia in Diabetes;Contemporary Diabetes;2023

3. Bioactivity of Dietary Polyphenols: The Role in LDL-C Lowering;Foods;2021-11-02

4. Hyperalphalipoproteinemia and Beyond: The Role of HDL in Cardiovascular Diseases;Life;2021-06-18

5. Is Anacetrapib Better Than Its CETP Inhibitor Counterparts?;Cardiology in Review;2019-09